Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 16, Issue 7, Pages -Publisher
SPRINGER
DOI: 10.1007/s11910-016-0667-0
Keywords
Muscular dystrophy; Genetics; Facioscapulohumeral dystrophy; DUX4; SCHMD1
Categories
Funding
- NIH
- FSH Society
- aTyr Pharma
- Acceleron
Ask authors/readers for more resources
Facioscapulohumeral muscular dystrophy (FSHD) is a clinically recognizable and relatively common muscular dystrophy. It is inherited mostly as an autosomal dominant disease or in a minority of cases, in a digenic pattern. The disease manifestation is variable and most likely dependent on genetic and epigenetic factors. We review the history, epidemiology, clinical presentation, and genetics of the disease, present the recently elucidated molecular pathogenesis, discuss the pathology and the possible consequence of the inflammation seen in the muscle biopsies, and consider future treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available